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Felypressin Increases Blood Pressure During Dental Procedures in 
Hypertensive Patients
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Abstract
Background: Felypressin has been added to local anesthetic to increase the length of the anesthetic effect and reduce toxicity 
during dental procedures. However, the effect on blood pressure remains uncertain, and this may be highly relevant in the 
dental treatment of hypertensive patients. 
Objective: To investigate the effect of felypressin on blood pressure in hypertensive patients with controlled BP. 
Methods: 71 subjects with these characteristics and in need of periodontal treatment were studied. After 10 minutes 
of rest, local anesthesia (prilocaine) was infiltrated with and without addition of felypressin. Then, a deep subgingival 
scaling was performed. Blood pressure was measured by an automated oscillometric device (DIXTAL DX2010). Ten 
minutes after the administration of the anesthetic, peak anesthetic action was recorded. The State-Trait Anxiety Inventory 
(STAI) was used to assess the patients’ trait anxiety. 
Results: Systolic blood pressure increased after anesthesia, regardless of association with felypressin, throughout the 
dental procedure (p<0.05) and this response can be explained, at least in part, by the trait anxiety levels of the subjects. 
However, a further increase in diastolic blood pressure was observed when prilocaine was associated with felypressin 
(p<0.05), but this response did not change with trait anxiety levels. 
Conclusion: Felypressin increased the diastolic blood pressure of hypertensive patients with controlled blood pressure. 
Patients with high trait anxiety presented increases in systolic blood pressure upon some procedures, suggesting that an 
increase in blood pressure might also be related to fear or anxiety. (Arq Bras Cardiol 2012;99(2):724-731)
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Introduction
Felypressin is a synthetic hormone of the posterior pituitary 
lobe characterized by vasoconstrictor properties that is widely 
used in dental procedures1. Its vasoconstrictor action seems 
to be mediated by V1 receptors of the blood vessel smooth 
muscle cells2. However, it is noteworthy that the V1 receptor-
mediated vasoconstrictor action is dependent on territory, 
since vessels of skeletal muscles and skin are more sensitive 
than renal vessels2. Anyway, felypressin has been widely 
added to local anesthetic solutions to increase the duration 
of the anesthetic effect and reduce the risk of toxicity during 
dental procedures3. Since its benefits are undeniable, its use 
is recommended by the Therapeutic Council of Dentistry 
of the United States of America3 in association with all local 
anesthetics, because the absence of a vasoconstrictor promotes 
fast absorption of the anesthetic and, consequently, low 
anesthetic effectiveness. 
In Brazil, where hypertension affects 22-44% of the adult 
population4, dental surgeons frequently have to provide 
dental care to hypertensive patients. However, despite the 
aforementioned benefits for dental procedures, it is not 
yet clear if felypressin in addition with prilocaine increases 
arterial blood pressure (BP), especially in subjects with 
special conditions, as is the case of hypertensive patients5,6. 
Is true that the level of the felypressin-related blood pressure 
increases might be low; nonetheless, some subgroups such 
as hypertensive subjects may benefit from efforts to reduce a 
further felypressin-related cardiovascular risk. Furthermore, 
that the choice of the local anesthetic seems to influence 
the hemodynamic response during dental procedures7,8 and, 
therefore, in the absence of any interaction with adrenergic 
receptors, it has been suggested that felypressin presents a 
lower incidence of side effects on hemodynamic responses9. 
For all these reasons, it is important to investigate the effect 
of felypressin on BP in hypertensive patients.
Another aspect to be considered is the individual 
response to stress during dental procedures. It is known that 
the response to a particular stressor stimulus is greater in 
hypertensive than in normotensive subjects10. Therefore, the 
possible pain caused by dental procedures without anesthesia 
or even in situations of ineffective anesthesia can produce 
stress for the patient, resulting in the release of endogenous 
catecholamine, which  sometimes reaches higher levels than 
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in a comfortable dentist’s chair with the back at an angle of 
45º for 10 minutes. After this, their trait anxiety level was 
assessed and they were classified as patients with low or 
with high anxiety level. Subsequently, the dentist performed 
the assessment of oral health and verified the presence of 
periodontal disease. For this purpose, periodontal disease 
was diagnosed according to the periodontal index criteria 
(Periodontal Screening & Recording - PSR). Briefly, this 
index identifies the presence of gingival inflammation and of 
aggravating local factors such as plaque and tartar attacking 
the gingival and periodontal tissue13. Patients who did not 
fulfill these criteria were excluded. Then, to familiarize them 
with the procedures, all patients were submitted to subgingival 
scaling without anesthetic procedures, since subgingival scaling 
is not painful.  
Anxiety assessment
The State-Trait inventory (STAI)14 was used to assess the 
patients’ anxiety level. This inventory is composed of two parts, 
with 20 statements each, and determines how the person 
usually feels in his/her life based on a scale, with a score range 
from 20 to 80. Thus the patients were classified according to 
their score as presenting “low anxiety” (score below or equal 
to 25) or “high anxiety” (score above 25).
Blood pressure
During the experimental session, BP was measured in a 
triplicate way and the mean was calculate for each period 
(rest, local anesthetic, subgingival scaling and anesthetic peak) 
with an automated oscillometric device (DIXTAL - model DX 
2010, São Paulo, Brazil) that is the result of the perfecting 
of DIXTAL - model DX 271014, validated according to the 
international regulations15. The cuff used was the adequate 
size for the circumference of the patient’s dominant arm: a) 
“adult” cuff with a 13 x 24cm inflatable bag for patients with 
arm circumference of 24 x 32cm; and, b) “obese” cuff with a 
17 x 32cm inflatable bag for patients with arm circumference of 
32 x 42cm. During the measurement, the cuff was positioned 
on the arm and adjusted for the height of the left ventricle16. 
Figure 1 - Experimental design
the aggregate amount contained in a tube of anesthesia1. Thus, 
dental procedures also might increase BP as a result of fear 
or anxiety11, in addition to a possible increase in BP due to 
the action of felypressin12, especially in hypertensive patients.
We hypothesized that BP might increase in the presence 
of felypressin during dental procedures, and the aim of this 
study was to investigate the effect of anesthesia, associated or 
not with felypressin on the BP of drug-controlled hypertensive 
patients during periodontal treatment.
Methods and Materials
The present study was performed as an open-label, 
randomized, two-way, two-treatment, single-dose study, after 
two hours of fasting, and the treatments were separated by 
a wash-out period of 10 minutes between the interventions 
(prilocaine or prilocaine plus felypressin) to comply with 
the crossover method proposed. Each subject was assigned 
a unique identification number and during the entire study, 
all the procedures were carried out by the same researchers, 
with a standardized protocol. The procedures were 
performed in accordance with the guidelines of the Helsinki 
Declaration for human experimentation and approved by the 
Ethics Committee of the General Hospital of the University of 
Sao Paulo, Brazil. All volunteers signed an informed consent 
form prior to their participation. The experimental design is 
present in Figure 1.
Subjects
Seventy-one hypertensive patients under antihypertensive 
treatment and with controlled BP as evaluated upon their 
last medical visit (systolic and diastolic BP lower than 140/90 
mmHg, respectively) were investigated. The sample included 
patients of both genders in need of periodontal treatment. 
Patients who presented diabetes mellitus, renal, coronary, 
heart or liver failure, and pregnant women were excluded.
Preliminary assessments
All patients underwent an initial dental examination. At 
arrival at the dentist’s office, they were placed to rest, seated 
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Periodontal treatment
During the periodontal treatment, all patients were 
instructed to take their antihypertensive drugs at 8:00 am, 
to ensure the antihypertensive action at the same time of the 
experimental session. The patients arrived at the dental office 
at 2:00 pm, after a postprandial period of 2 hours, in order 
to prevent any effect of food on BP.
During the pre-intervention period, defined as REST, the 
patients were seated in a comfortable dentist’s chair with the 
back at an angle of 45º for 10 minutes, during which their BP 
was measured every two minutes. Then, the local anesthetic 
(prilocaine), with or without felypressin, was infiltrated using a 
syringe with a 30G carpule needle. This procedure was named 
as LOCAL ANESTHETIC period and lasted four minutes. The 
quantities used were 144mg 4% prilocaine without felypressin 
(2 tubes) and 108mg prilocaine with 0.11 UI of felypressin (2 
tubes), totaling four tubes. It is noteworthy that the difference 
in the amount of prilocaine is due to commercial availability 
of local anesthetic, in which is only found prilocaine 3% with 
felypressin 0.03 IU, and prilocaine 4% without vasoconstrictor. 
During this step, BP was measured twice. After the anesthesia, 
the technical procedure for deep subgingival scaling was 
performed and BP was again measured every two minutes. 
This dental procedure, defined as SUBGINGIVAL SCALING 
period, is always painful and justifies the use of an anesthetic. 
The anesthetic peak of prilocaine or prilocaine associated 
with felypressin was reached 10 minutes after the anesthetic 
injection, and BP was measured twice. This period was defined 
as ANESTHETIC PEAK period. The instruments used during 
the deep subgingival scaling were McCall and Grayce curettes, 
sickles of the type scraped, and periodontal probes.
Anesthetic simulation
A subsample of 34 patients was invited to engage in 
an anesthetic simulation session one week before the 
experimental session, in which an anesthetic simulation 
with an empty syringe and needle was performed, in order 
to evaluate the effect of the procedure on BP. The details of 
the anesthetic simulation session were as described: rest, 
evaluation of oral health, and subgingival scaling in the 
preliminary assessments. This procedure was performed one 
week before the experimental session, immediately after the 
dental evaluation to assess the need for dental treatment.
Statistical analysis
Considering a power of 80% and an alpha error of 5%, 
the minimal sample size necessary to detect a difference of 
10 mmHg in BP was calculated to be 37 subjects.
Data normality was checked by means of the Shapiro-Wilks 
test, using the statistical package SPSS for Windows (Statistical 
Package for Social Sciences, version 13.0, Chicago, IL, USA).
The effects of prilocaine associated or not with felypressin 
were compared by a two-way ANOVA test for repeated 
measures, establishing anesthetic (prilocaine or prilocaine + 
felypressin) and stage (rest, anesthetic, subgingival scaling and 
anesthetic peak) as the main factors. Post-hoc comparisons 
were made using the Newman-Keuls test. Values of p < 0.05 
were considered statistically significant, and data are presented 
as means and standard error. The software package used for 
these analyses was STATISTICA (Statistic for Windows 4.3, 
StatSoft Inc, Tulsa, OK, USA, 1993).
The primary outcomes were changes in office BP during 
painful dentistry procedures and the effects of prilocaine 
associated or not with felypressin.
Results
Seventy-one hypertensive patients (44 women and 
27 men) with BP controlled by antihypertensive treatment 
and in need of periodontal treatment completed the study. 
The characterization of the sample is presented in Table 1. 
It is noteworthy that the trait anxiety was measured in 
36 patients only, because the other volunteers did not fulfill 
the forms completely.
The effects of the anesthetic simulation session are 
presented in Figure 2.
During the anesthetic simulation session, both systolic and 
diastolic BP increased significantly (p<0.05) compared to the 
other steps of the session (rest, assessment of oral health, and 
subgingival scaling).
Figure 3 shows the effect of anesthetic added or not with 
felypressin on BP. Regarding systolic BP, a significant effect of 
the stage factor was identified, since prilocaine, associated or 
not with felypressin, increased the systolic BP throughout the 
Table 1 – Demographic characteristics of the sample
n (%)
Patients 71
      Male 27 (38)
      Female 44 (62)
Age (y) 48±12
BMI (kg/m2) 28.1±4.9
      < 30 kg/m2 59 (83)
      > 30 kg/m2 12 (17)
Ethnic group 
      Caucasian 40 (56)
      Non-Caucasian 31 (44)
Classes of antihypertensive drugs 
      Angiotensin II blocker 15 (21)
      Calcium channel antagonist 25 (35)
      Beta-blockers 34 (48)
      Inhibitor of angiotensin converting enzyme 44 (62)
      Adrenergic inhibitor 07 (10)
      Direct vasodilators 01 (01)
Trait anxiety 36
      Present 15 (42)
      Absent 21 (58)
726
Original Article
Arq Bras Cardiol 2012;99(2):724-731
Bronzo et al.
Felypressin during dental procedures
period of the dental visit (p<0.05). However, regarding the 
diastolic BP, a significant interaction between the main factors 
(condition and stage) was found. Thus, diastolic BP increased 
during all dental procedures under both conditions, but this 
increase was greater when the anesthetic was associated with 
felypressin (p<0.05).
In a complementary analysis, subjects with low (score ≤ 25) 
and high (score >25) trait anxiety were compared, and it 
was observed that the systolic BP increased significantly 
during anesthesia and subgingival scaling only in the patients 
with highest trait anxiety (Figure 4). However, no significant 
difference was observed in diastolic BP (p>0.05). 
Discussion
The originality of the present study is the finding that 
anesthetic associated with felypressin increases the diastolic 
BP of hypertensive patients with medication-controlled BP. 
We found here that acute infusion of prilocaine associated 
with felypressin promotes an increase in diastolic but not in 
systolic BP. Our study is in agreement with that of Inagawa et 
al17, who found that, in male Japanese white tracheotomized 
rabbits, the diastolic BP increased significantly, without change 
in systolic BP. However, our study differs from others with 
human experimentation that showed that felypressin is not 
associated with BP increases18. This difference can be justified 
by the fact that we investigated hypertensive patients with 
controlled BP, and the effect of felypressin might be different 
in hypertensive patients with uncontrolled BP, because the 
presence of an already elevated BP may cover up the BP 
response to felypressin. Furthermore, it is noteworthy that V1 
receptors can trigger a powerful vasoconstrictor response19 and 
might therefore contribute to the tonic control of circulation, 
because specific antagonists of V1 receptors produce a slight, 
but long-lasting fall in BP2. However, the effect of felypressin 
on the vascular tone is still a controversial issue.
The use of a local anesthetic, whether associated or not 
with a vasoconstrictor, in the dental care of hypertensive 
patients and its adverse effects on BP were evaluated by several 
authors3,16,20, but there are no conclusive studies on this topic 
up to far. In the present study, we identified a BP elevation 
during all procedures, and a partial analysis of the data showed 
that this elevation tended to be more pronounced during the 
anesthetic procedure. Thus, two hypotheses arise: a) prilocaine 
also increases BP; and b) dentistry procedures are stressful 
enough to increase BP, regardless of prilocaine. Based on this 
initial analysis, we decided to include an anesthetic simulation 
procedure with an empty syringe and needle, to monitor the 
BP at the time of anesthesia. During this simulation, there was 
a significant elevation in systolic BP, suggesting that fear and 
anxiety can trigger such a response. In fact, Gortzack et al17 
also demonstrated a more pronounced BP elevation during 
the administration of a local anesthetic, followed by reduction 
after removal of the needle.
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Figure 2 - Effect of anesthetic simulation on BP - Blood Pressure. In the upper and lower edge of the bar are shown the systolic and diastolic BP values (mean±SD), respectively.  
* Significantly different from rest; † Significantly different from oral health assessment; ‡ Significantly different from supragingival scaling. (p<0.05).
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Figure 3 - Effect of felypressin on BP - Blood Pressure. 
* Significantly different from rest; # Significantly different from prilocaine. (p<0.05).
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Figure 4 - Level of BP - Blood Pressure. In patients with low (n=21) and high (n=15) trait anxiety during dental procedures. 
* Significantly different from the same group in the rest; # Significantly different from low trait anxiety groups, respectively (p<0.05).
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It has been suggested that beta-blockers might reduce the 
release of endogenous adrenaline16 and, therefore, interfere 
with the BP response. Coincidentally, in our study, 58% of the 
subjects were under beta-blocker treatment and 58% of the 
subpopulation in which the level of stress was assessed showed 
mild anxiety. It is therefore possible to think that the use of 
beta-blockers might affect the BP responses to stress. Thus, we 
decided to evaluate our patients separately according to their 
use or not of beta-blockers (data not shown). However, no 
significant difference was found for either systolic or diastolic 
BP during the entire experimental protocol (p>0.05).
It is known that the response to a particular stressor stimulus 
is greater in hypertensive than in normotensive subjects. 
Furthermore, it is noteworthy that among hypertensive 
patients there is variability in stress index. In a subsample of 
our study, 42% of the subjects were classified as high anxiety 
subjects and prilocaine without vasoconstrictor was found to 
promote a systolic BP increase (Figure 4); yet, when associated 
to felypressin, this response was not observed (p>0.05), 
suggesting that blood pressure response to felypressin is not 
influenced by the anxiety level.
Conclusions
In conclusion, the present findings indicate that felypressin 
increases the diastolic BP, regardless of its anesthetic properties. 
Furthermore, a significant increase in systolic BP occurs in 
hypertensive patients whose BP is controlled by antihypertensive 
treatment. Patients with high trait anxiety presented systolic BP 
increases upon some procedures, suggesting that an increase 
in BP might also be related to fear or anxiety. Finally, this 
study contributed to unraveling the hemodynamic risk that 
hypertension can present with prilocaine + felypressin use. 
However, it not belies the dentistry practice that is widely used 
in the clinic routine for this population.
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